7 Oct21:14 Business Tempus Deepens Cancer Vaccine Collaboration With Moderna, Merck Tempus expands its cancer vaccine collaboration with Moderna and Merck on intismeran autogene, as Moderna's 2026 rally draws fresh valuation scrutiny. Keith Howard · 7 Oct